Janmet 1000mg Tablet is used in addition to diet and exercise to improve blood sugar control in adults with type 2 diabetes.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Sitagliptin+Metformin Hydrochloride is a combination medication that includes Sitagliptin (a DPP4 inhibitor) and Metformin (a Biguanide), both of which belong to the class of anti-diabetic drugs. This combination is used to treat type 2 diabetes, a condition characterized by either inadequate insulin production or resistance to insulin's effects in the body. When not properly managed, it can lead to elevated blood sugar levels.
Sitagliptin works as a DPP-4 inhibitor by increasing the levels of natural substances that help lower blood sugar when it's high. Metformin, on the other hand, is a biguanide that reduces glucose production in the liver, slows glucose absorption in the intestines, and enhances the body's responsiveness to insulin. Together, these mechanisms help prevent blood glucose levels from spiking excessively after meals.
To ensure the best results and minimize side effects, it's recommended to take Sitagliptin+Metformin Hydrochloride with food and at the same time each day. Your doctor will determine the appropriate dose based on your condition, and this dosage may be adjusted over time.
Hypoglycemia (low blood sugar) is a common side effect of Sitagliptin+Metformin Hydrochloride, and it can manifest with symptoms such as dizziness, sweating, palpitations, hunger, dry mouth, and skin. To prevent hypoglycemia, it's important not to skip meals and to carry a source of sugar with you.
Other potential side effects may include changes in taste, nausea, diarrhea, stomach pain, headache, and upper respiratory symptoms.
Do not discontinue Sitagliptin+Metformin Hydrochloride without consulting your doctor, even if you start feeling better, as blood sugar levels can fluctuate. Abruptly stopping this medication may lead to increased sugar levels, which could raise the risk of complications such as retinopathy (eye damage), nephropathy (kidney damage), and neuropathy (nerve damage).
This medication is not suitable for individuals with type 1 diabetes mellitus or severe kidney or liver disease. Inform your doctor if you have any heart conditions, are pregnant, planning to become pregnant, or are breastfeeding while taking Sitagliptin+Metformin Hydrochloride. Always follow your healthcare provider's guidance for the best management of your diabetes.
It is considered unsafe to consume alcohol while taking Janmet 1000. Alcohol can affect blood glucose levels and may interfere with the medication's effectiveness.
Common adverse reactions include diarrhea, upper respiratory tract infection, headache, hypoglycemia, nausea/vomiting, flatulence, stomach discomfort, indigestion, asthenia, and headache.
This medication is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate. It should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. It has not been studied in patients with a history of pancreatitis.
Janmet 1000mg Tablet combines two antihyperglycemic agents with complementary mechanisms of action to improve glycemic control in patients with type 2 diabetes. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that slows the inactivation of incretin hormones, leading to increased insulin release and decreased glucagon levels in a glucose-dependent manner. Metformin, on the other hand, reduces hepatic glucose production, decreases intestinal glucose absorption, and increases peripheral glucose uptake and utilization.
The dosage of this tablet should be individualized based on the patient's current regimen, effectiveness, and tolerability, not exceeding the maximum recommended daily doses of 100 mg sitagliptin and 2000 mg metformin. It is typically given twice daily with meals, with gradual dose escalation to reduce gastrointestinal side effects associated with metformin.
The recommended starting dose in patients not currently treated with metformin is 50 mg sitagliptin/500 mg metformin hydrochloride twice daily. The starting dose in patients already on metformin should provide 50 mg sitagliptin twice daily (100 mg total daily dose) and the current metformin dose. For patients taking metformin 850 mg twice daily, the recommended starting dose of this tablet is 50 mg sitagliptin/1000 mg metformin hydrochloride twice daily.
There are potential interactions with cationic drugs, phenprocoumon, and levothyroxine. Caution is advised when using this medication in combination with these drugs.
This tablet is contraindicated in patients with renal disease or dysfunction, acute or chronic metabolic acidosis, a history of serious hypersensitivity reactions to this tablet or sitagliptin, and during radiologic studies involving intravascular administration of iodinated contrast materials.
Use during pregnancy is recommended only if clearly needed, and caution should be exercised when used by nursing women as it is not known whether sitagliptin is excreted in human breast milk.
Lactic acidosis is a potential risk, especially in conditions like sepsis, dehydration, excess alcohol intake, hepatic impairment, renal impairment, and acute congestive heart failure. Regular monitoring of thyroid-stimulating hormone (TSH) levels and vitamin B12 levels is recommended. It should be temporarily discontinued during periods of stress and reduced fluid and food intake. Caution is advised in cases of hypersensitivity reactions, and the drug should be discontinued if severe reactions occur.
Store below 25°C in a dry place away from light and keep out of the reach of children.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.